On January 31, 2024, the Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission updated the Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Updates include those to reflect new data and publications and to incorporate gender-inclusive language. For a list of recent updates, please see What's New in the Guidelines.
